首页> 外文期刊>International Journal of Research in Medical Sciences >Psychotropic drug utilization in psychiatric outpatient department of a tertiary care teaching hospital in India
【24h】

Psychotropic drug utilization in psychiatric outpatient department of a tertiary care teaching hospital in India

机译:印度三级教学医院的精神科门诊患者的精神药物使用情况

获取原文
           

摘要

Background: Although psychotropic medications have had a remarkable impact on psychiatric practice that legitimately can be called revolutionary, their utilization and consequences on real life effectiveness and safety in actual clinical practice need continuous study. Methods: The current retrospective study of six months’ duration was designed to assess the utilization of antipsychotics and its prescribing pattern in a tertiary care hospital of south India, which included prescriptions of patients suffering from a psychiatric illness with at least one psychotropic drug of all ages and both sexes. Results: Out of 150 cases reviewed, 46% were of schizophrenia, where male (60.67%) at higher incidence of psychiatric illness, and maximum patients were under the age group of 29-39 years (54.67%). In present study of 355 prescribed drugs 72.67% were psychotropic medications. As per World Health Organization/International Network for Rational Use of Drugs (INRUD) drug use indicators average number of drugs per prescription (2.37%), average number of psychotropic drugs per prescription (1.72%), psychotropic drugs prescribed as Fixed Dose Combinations (FDCs) was 26.36%, and percentage of drugs prescribed by generic name (91.08%). In our study, 48.09% of psychotropic drugs were utilized in the treatment of schizophrenia, diazepam (17.06%) was the only psychotropic medication distributed in the management of all three observed psychiatric disorders and the study showed a higher utilization of psychotropic drugs as FDCs (25.98%) in the management of schizophrenia. Conclusions: The study advocated an overall rational utilization of psychotropic drugs with a fewer deviations due to socio-economic status of patients and prescription practices of healthcare providers.
机译:背景:尽管精神药物对精神病学实践产生了显着影响,可以合法地称为革命性药物,但在实际临床实践中,它们的使用以及对现实生活中的有效性和安全性的影响仍需继续研究。方法:目前为期六个月的回顾性研究旨在评估印度南部一家三级医院的抗精神病药的使用及其处方方式,其中包括患有精神疾病的患者的处方药,其中至少有一种精神药物年龄和性别。结果:在所审查的150例患者中,精神分裂症占46%,其中男性(60.67%)患有精神疾病的发生率更高,并且最大的患者年龄在29-39岁之间(54.67%)。在目前对355种处方药的研究中,有72.67%是精神药物。根据世界卫生组织/国际合理使用药物网络(INRUD)的药物使用指标,每张处方平均药物数量(2.37%),每张处方平均精神药物数量(1.72%),以固定剂量组合形式指定的精神药物( FDCs)为26.36%,而以通用名称指定的药物百分比为(91.08%)。在我们的研究中,48.09%的精神药物被用于治疗精神分裂症,地西epa(17.06%)是在所有三种观察到的精神疾病的管理中唯一分配的精神药物,并且该研究表明,精神药物作为FDC的利用率更高( 25.98%)在精神分裂症的管理中。结论:该研究提倡对精神药物进行整体合理利用,并应减少因患者的社会经济状况和医疗保健提供者的处方习惯而引起的偏差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号